Yan Zhu
Research Subjects
Yan Zhu has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Bo-En Wang
Ruijin Hospital 2 Shanghai
15 shared publications - Di Fu
Shanghai Institute of Hematology 4
15 shared publications - Hao-Xing Bian
Ruijin Hospital 2 Shanghai
15 shared publications - Jiahao Chen
Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai, China
15 shared publications - Li Wang
Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai China
15 shared publications - Peng-Peng Xu
Shanghai ruijin hospital 8 Shanghai
15 shared publications
Latest Publications
- Open Access
- 3 September 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S7 from Tumor-Infiltrating Clonal Hematopoiesis Is Associated with Adverse Clinical Outcomes in Diffuse Large B-cell Lymphoma
Supplementary Figure S7 shows the results of ligand receptor interaction from the cell–cell communication analyses using Cellchat.
- 3 September 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S7 from Tumor-Infiltrating Clonal Hematopoiesis Is Associated with Adverse Clinical Outcomes in Diffuse Large B-cell Lymphoma
Supplementary Figure S7 shows the results of ligand receptor interaction from the cell–cell communication analyses using Cellchat.
- Open Access
- 3 September 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S5 from Tumor-Infiltrating Clonal Hematopoiesis Is Associated with Adverse Clinical Outcomes in Diffuse Large B-cell Lymphoma
Supplementary Figure S5 shows association of CAPS scores with DLBCL LymphGen and LME subtypes, as well as patient outcomes.
- 3 September 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S5 from Tumor-Infiltrating Clonal Hematopoiesis Is Associated with Adverse Clinical Outcomes in Diffuse Large B-cell Lymphoma
Supplementary Figure S5 shows association of CAPS scores with DLBCL LymphGen and LME subtypes, as well as patient outcomes.
- Open Access
- 3 September 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S4 from Tumor-Infiltrating Clonal Hematopoiesis Is Associated with Adverse Clinical Outcomes in Diffuse Large B-cell Lymphoma
Supplementary Figure S4 shows the enrichment scores of CAPS genes in comparing TI-CH+ versus TI-CH− patients, and across different cell types in human DLBCL scRNA-seq datasets, as well as human and mouse CH scRNA-seq datasets.
- 3 September 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S4 from Tumor-Infiltrating Clonal Hematopoiesis Is Associated with Adverse Clinical Outcomes in Diffuse Large B-cell Lymphoma
Supplementary Figure S4 shows the enrichment scores of CAPS genes in comparing TI-CH+ versus TI-CH− patients, and across different cell types in human DLBCL scRNA-seq datasets, as well as human and mouse CH scRNA-seq datasets.
- Open Access
- 3 September 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S1 from Tumor-Infiltrating Clonal Hematopoiesis Is Associated with Adverse Clinical Outcomes in Diffuse Large B-cell Lymphoma
Supplementary Figure S1 shows the sequencing coverage and TI-CH+ percentage in WGS and WES samples, and the association between TI-CH and characteristics of DLBCL patients.
- 3 September 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S1 from Tumor-Infiltrating Clonal Hematopoiesis Is Associated with Adverse Clinical Outcomes in Diffuse Large B-cell Lymphoma
Supplementary Figure S1 shows the sequencing coverage and TI-CH+ percentage in WGS and WES samples, and the association between TI-CH and characteristics of DLBCL patients.
- Open Access
- 3 September 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S3 from Tumor-Infiltrating Clonal Hematopoiesis Is Associated with Adverse Clinical Outcomes in Diffuse Large B-cell Lymphoma
Supplementary Figure S3 shows the results of deconvolution analysis comparing TI-CH+ versus TI-CH− patients using bulk RNA-seq data, and the results of multivariate survival analysis adjusted for percentages of myeloid and T cells infiltration.
- 3 September 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S3 from Tumor-Infiltrating Clonal Hematopoiesis Is Associated with Adverse Clinical Outcomes in Diffuse Large B-cell Lymphoma
Supplementary Figure S3 shows the results of deconvolution analysis comparing TI-CH+ versus TI-CH− patients using bulk RNA-seq data, and the results of multivariate survival analysis adjusted for percentages of myeloid and T cells infiltration.
- Open Access
- 3 September 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S4 from Tumor-Infiltrating Clonal Hematopoiesis Is Associated with Adverse Clinical Outcomes in Diffuse Large B-cell Lymphoma
Supplementary Table S4 shows all the differentially expressed genes in TI-CH+ versus TI-CH− DLBCL patients by bulk RNA-seq analysis.
- 3 September 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S4 from Tumor-Infiltrating Clonal Hematopoiesis Is Associated with Adverse Clinical Outcomes in Diffuse Large B-cell Lymphoma
Supplementary Table S4 shows all the differentially expressed genes in TI-CH+ versus TI-CH− DLBCL patients by bulk RNA-seq analysis.
- Open Access
- 3 September 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S5 from Tumor-Infiltrating Clonal Hematopoiesis Is Associated with Adverse Clinical Outcomes in Diffuse Large B-cell Lymphoma
Supplementary Table S5 shows the results of gene set enrichment analysis with the bulk RNA-seq data of TI-CH+ versus TI-CH− DLBCL patients.
- 3 September 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S5 from Tumor-Infiltrating Clonal Hematopoiesis Is Associated with Adverse Clinical Outcomes in Diffuse Large B-cell Lymphoma
Supplementary Table S5 shows the results of gene set enrichment analysis with the bulk RNA-seq data of TI-CH+ versus TI-CH− DLBCL patients.
- Open Access
- 3 September 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S6 from Tumor-Infiltrating Clonal Hematopoiesis Is Associated with Adverse Clinical Outcomes in Diffuse Large B-cell Lymphoma
Supplementary Figure S6 shows association of TI-CH status with Ecotyper classifications and cell states, and the association of CAPS scores with Ecotyper classifications and cell states.
- 3 September 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S6 from Tumor-Infiltrating Clonal Hematopoiesis Is Associated with Adverse Clinical Outcomes in Diffuse Large B-cell Lymphoma
Supplementary Figure S6 shows association of TI-CH status with Ecotyper classifications and cell states, and the association of CAPS scores with Ecotyper classifications and cell states.
- Open Access
- 3 September 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S1 from Tumor-Infiltrating Clonal Hematopoiesis Is Associated with Adverse Clinical Outcomes in Diffuse Large B-cell Lymphoma
Table S1 includes all the CH-related gene mutations considered in this study.
- 3 September 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S1 from Tumor-Infiltrating Clonal Hematopoiesis Is Associated with Adverse Clinical Outcomes in Diffuse Large B-cell Lymphoma
Table S1 includes all the CH-related gene mutations considered in this study.
- Open Access
- 3 September 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S2 from Tumor-Infiltrating Clonal Hematopoiesis Is Associated with Adverse Clinical Outcomes in Diffuse Large B-cell Lymphoma
Supplementary Table S2 includes all the DLBCL mutations excluded for TI-CH analysis in this study.
- 3 September 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S2 from Tumor-Infiltrating Clonal Hematopoiesis Is Associated with Adverse Clinical Outcomes in Diffuse Large B-cell Lymphoma
Supplementary Table S2 includes all the DLBCL mutations excluded for TI-CH analysis in this study.